ID   Q8IL11_PLAF7            Unreviewed;       605 AA.
AC   Q8IL11;
DT   01-MAR-2003, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2003, sequence version 1.
DT   22-JUL-2015, entry version 88.
DE   SubName: Full=M17 leucyl aminopeptidase {ECO:0000313|EMBL:AAN37052.1};
GN   Name=LAP {ECO:0000313|EMBL:AAN37052.1};
GN   ORFNames=PF14_0439 {ECO:0000313|EMBL:AAN37052.1};
OS   Plasmodium falciparum (isolate 3D7).
OC   Eukaryota; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX   NCBI_TaxID=36329 {ECO:0000313|EMBL:AAN37052.1, ECO:0000313|Proteomes:UP000001450};
RN   [1] {ECO:0000313|EMBL:AAN37052.1, ECO:0000313|Proteomes:UP000001450}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Isolate 3D7 {ECO:0000313|Proteomes:UP000001450};
RX   PubMed=12368864; DOI=10.1038/nature01097;
RA   Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W.,
RA   Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K.,
RA   Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S.,
RA   Chan M.-S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S.,
RA   Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B.,
RA   Martin D.M.A., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A.,
RA   McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C.,
RA   Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W.,
RA   Fraser C.M., Barrell B.;
RT   "Genome sequence of the human malaria parasite Plasmodium
RT   falciparum.";
RL   Nature 419:498-511(2002).
RN   [2] {ECO:0000213|PDB:3KQX, ECO:0000213|PDB:3KQZ, ECO:0000213|PDB:3KR4}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 84-605 IN COMPLEX WITH
RP   MAGNESIUM AND ZINC.
RX   PubMed=20133789; DOI=10.1073/pnas.0911813107;
RA   McGowan S., Oellig C.A., Birru W.A., Caradoc-Davies T.T., Stack C.M.,
RA   Lowther J., Skinner-Adams T., Mucha A., Kafarski P., Grembecka J.,
RA   Trenholme K.R., Buckle A.M., Gardiner D.L., Dalton J.P.,
RA   Whisstock J.C.;
RT   "Structure of the Plasmodium falciparum M17 aminopeptidase and
RT   significance for the design of drugs targeting the neutral
RT   exopeptidases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2449-2454(2010).
RN   [3] {ECO:0000213|PDB:3T8W}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 84-605 IN COMPLEX WITH ZINC.
RX   PubMed=21844374; DOI=10.1073/pnas.1105601108;
RA   Harbut M.B., Velmourougane G., Dalal S., Reiss G., Whisstock J.C.,
RA   Onder O., Brisson D., McGowan S., Klemba M., Greenbaum D.C.;
RT   "Bestatin-based chemical biology strategy reveals distinct roles for
RT   malaria M1- and M17-family aminopeptidases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:E526-E534(2011).
RN   [4] {ECO:0000213|PDB:4K3N}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 84-605 IN COMPLEX WITH ZINC.
RX   PubMed=23713488;
RA   Kannan Sivaraman K., Paiardini A., Sienczyk M., Ruggeri C.,
RA   Oellig C.A., Dalton J.P., Scammells P.J., Drag M., McGowan S.;
RT   "Synthesis and structure-activity relationships of phosphonic arginine
RT   mimetics as inhibitors of the M1 and M17 aminopeptidases from
RT   Plasmodium falciparum.";
RL   J. Med. Chem. 56:5213-5217(2013).
RN   [5] {ECO:0000213|PDB:4R6T, ECO:0000213|PDB:4R76, ECO:0000213|PDB:4R7M}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 84-605 IN COMPLEX WITH ZINC.
RX   PubMed=25299353;
RA   Mistry S.N., Drinkwater N., Ruggeri C., Sivaraman K.K., Loganathan S.,
RA   Fletcher S., Drag M., Paiardini A., Avery V.M., Scammells P.J.,
RA   McGowan S.;
RT   "Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and
RT   M17 metalloaminopeptidases by a novel series of hydroxamic acid-based
RT   inhibitors.";
RL   J. Med. Chem. 57:9168-9183(2014).
RN   [6] {ECO:0000213|PDB:4X2T}
RP   X-RAY CRYSTALLOGRAPHY (2.73 ANGSTROMS) OF 85-603 IN COMPLEX WITH ZINC.
RX   PubMed=25645579; DOI=10.1002/prot.24771;
RA   Drinkwater N., Bamert R.S., Sivaraman K.K., Paiardini A., McGowan S.;
RT   "X-ray crystal structures of an orally available aminopeptidase
RT   inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and
RT   PfA-M17.";
RL   Proteins 83:789-795(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014187; AAN37052.1; -; Genomic_DNA.
DR   RefSeq; XP_001348613.1; XM_001348577.1.
DR   PDB; 3KQX; X-ray; 2.01 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 3KQZ; X-ray; 2.39 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 3KR4; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 3KR5; X-ray; 2.56 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 3T8W; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 4K3N; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 4R6T; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 4R76; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 4R7M; X-ray; 2.85 A; A/B/C/D/E/F/G/H/I/J/K/L=84-605.
DR   PDB; 4X2T; X-ray; 2.73 A; A/B/C/D/E/F/G/H/I/J/K/L=85-603.
DR   PDBsum; 3KQX; -.
DR   PDBsum; 3KQZ; -.
DR   PDBsum; 3KR4; -.
DR   PDBsum; 3KR5; -.
DR   PDBsum; 3T8W; -.
DR   PDBsum; 4K3N; -.
DR   PDBsum; 4R6T; -.
DR   PDBsum; 4R76; -.
DR   PDBsum; 4R7M; -.
DR   PDBsum; 4X2T; -.
DR   ProteinModelPortal; Q8IL11; -.
DR   SMR; Q8IL11; 85-603.
DR   DIP; DIP-58533N; -.
DR   BindingDB; Q8IL11; -.
DR   ChEMBL; CHEMBL1293313; -.
DR   MEROPS; M17.008; -.
DR   PRIDE; Q8IL11; -.
DR   EnsemblProtists; PF14_0439:mRNA; PF14_0439:pep; PF14_0439.
DR   GeneID; 812021; -.
DR   KEGG; pfa:PF14_0439; -.
DR   EuPathDB; PlasmoDB:PF3D7_1446200; -.
DR   HOGENOM; HOG000243129; -.
DR   InParanoid; Q8IL11; -.
DR   KO; K01255; -.
DR   PhylomeDB; Q8IL11; -.
DR   BRENDA; 3.4.11.1; 4889.
DR   BRENDA; 3.4.11.20; 4889.
DR   EvolutionaryTrace; Q8IL11; -.
DR   Proteomes; UP000001450; Chromosome 14.
DR   GO; GO:0005829; C:cytosol; IDA:GeneDB.
DR   GO; GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IEA:InterPro.
DR   GO; GO:0008235; F:metalloexopeptidase activity; IEA:InterPro.
DR   HAMAP; MF_00181; Cytosol_peptidase_M17; 1.
DR   InterPro; IPR011356; Leucine_aapep/pepB.
DR   InterPro; IPR000819; Peptidase_M17_C.
DR   InterPro; IPR023042; Peptidase_M17_leu_NH2_pept.
DR   Pfam; PF00883; Peptidase_M17; 1.
DR   PRINTS; PR00481; LAMNOPPTDASE.
DR   PROSITE; PS00631; CYTOSOL_AP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminopeptidase {ECO:0000313|EMBL:AAN37052.1};
KW   Complete proteome {ECO:0000313|Proteomes:UP000001450};
KW   Hydrolase {ECO:0000313|EMBL:AAN37052.1};
KW   Magnesium {ECO:0000213|PDB:3KR4};
KW   Metal-binding {ECO:0000213|PDB:4X2T};
KW   Protease {ECO:0000313|EMBL:AAN37052.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000001450};
KW   Zinc {ECO:0000213|PDB:4X2T}.
FT   METAL       374    374       Zinc 1. {ECO:0000213|PDB:4X2T}.
FT   METAL       379    379       Magnesium. {ECO:0000213|PDB:3KR4}.
FT   METAL       379    379       Zinc 1. {ECO:0000213|PDB:4X2T}.
FT   METAL       379    379       Zinc 2. {ECO:0000213|PDB:3KQZ,
FT                                ECO:0000213|PDB:3KR5,
FT                                ECO:0000213|PDB:3T8W}.
FT   METAL       399    399       Zinc 1. {ECO:0000213|PDB:4X2T}.
FT   METAL       459    459       Magnesium. {ECO:0000213|PDB:3KR4}.
FT   METAL       459    459       Zinc 2. {ECO:0000213|PDB:3KQZ,
FT                                ECO:0000213|PDB:3KR5,
FT                                ECO:0000213|PDB:3T8W}.
FT   METAL       461    461       Magnesium. {ECO:0000213|PDB:3KR4}.
FT   METAL       461    461       Zinc 1. {ECO:0000213|PDB:4X2T}.
FT   METAL       461    461       Zinc 2. {ECO:0000213|PDB:3KQZ,
FT                                ECO:0000213|PDB:3KR5,
FT                                ECO:0000213|PDB:3T8W}.
SQ   SEQUENCE   605 AA;  67821 MW;  CA30B9A341AB9F44 CRC64;
     MYFSSLCKFL PISEKEKIYL NIVKKRFCKS NIYYNNNNNN IINYNKRGLK FYPFCNNLKK
     NINFVNINNK KGINFHSINK ERKMASEVPQ VVSLDPTSIP IEYNTPIHDI KVQVYDIKGG
     CNVEEGLTIF LVNNPGKENG PVKISSKVND KNVSEFLKDE NMEKFNVKLG TSKHFYMFND
     NKNSVAVGYV GCGSVADLSE ADMKRVVLSL VTMLHDNKLS KLTVVFEINV DKNLFRFFLE
     TLFYEYMTDE RFKSTDKNVN MEYIKHLGVY INNADTYKEE VEKARVYYFG TYYASQLIAA
     PSNYCNPVSL SNAAVELAQK LNLEYKILGV KELEELKMGA YLSVGKGSMY PNKFIHLTYK
     SKGDVKKKIA LVGKGITFDS GGYNLKAAPG SMIDLMKFDM SGCAAVLGCA YCVGTLKPEN
     VEIHFLSAVC ENMVSKNSYR PGDIITASNG KTIEVGNTDA EGRLTLADAL VYAEKLGVDY
     IVDIATLTGA MLYSLGTSYA GVFGNNEELI NKILNSSKTS NEPVWWLPII NEYRATLNSK
     YADINNISSS VKASSIVASL FLKEFVQNTA WAHIDIAGVS WNFKARKPKG FGVRLLTEFV
     LNDAL
//
